Soluble form of FasL (sFasL) in adult asthma

Iranian Red Crescent Medical Journal

Volumn 11, Issue 3, 2009, Pages 301-305

  Daneshmandi, S ^a   Pourfathollah, Ali Akbar ^a   Pourpak, Z ^b   Heidarnazhad, H ^c  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Allergy; Asthma; IgE; sFasL

Indexed keywords

FAS LIGAND; IMMUNOGLOBULIN E; SOLUBLE FAS LIGAND; UNCLASSIFIED DRUG;

ADULT; ALLERGIC ASTHMA; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; MALE; PEAK EXPIRATORY FLOW; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

EID: 67749118326     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Seino K, Iwabuchi K, Kayagaki N, Miyata R, Nagaoka I, Matsuzawa A, Fukao K, Yagita H, Okumura K. Chemotactic activity of soluble Fas ligand against phagocytes. J Immunol 1998;161:4484-8. [9794371]
2. Gochuico BR, Miranda KM, Hessel EM, De Bie JJ, Van Oosterhout AJ, Cruikshank WW, Fine A. Airway epithelial Fas ligand expression: potential role in modulating bronchial inflammation. Am J Physiol 1998; 274:L444-9. [9530181]
3. Zietz C, Rumpler U, Stürzl M, Löhrs U. Inverse relation of Fas-ligand and tumor-infiltrating lymphocytes in angiosarcoma: indications of apoptotic tumor counterattack. Am J Pathol 2001; 159:963-70. [11549589]
4. De Paepe ME, Mao Q, Embree-Ku M, Rubin LP, Luks FI. Fas/FasL-mediated apoptosis in perinatal murine lungs. Am J Physiol Lung Cell Mol Physiol 2004;287:L730-742. [15355863] [doi:10.1152/ ajplung.00120.2004]
5. Basehore MJ, Howard TD, Lange LA, Moore WC, Hawkins GA, Marshik PL, Harkins MS, Meyers DA, Bleecker ER. A comprehensive evaluation of IL4 variants in ethnically diverse populations: association of total serum IgE levels and asthma in white subjects. J Allergy Clin Immunol 2004;114:80-7. [15241348] [doi: 10.1016/j.jaci.2004.05.035]
6. De Paepe ME, Rubin LP, Jude C, Lesieur-Brooks AM, Mills DR, Luks FI. Fas ligand expression coincides with alveolar cell apoptosis in late-gestation fetal lung development. Am J Physiol Lung Cell Mol Physiol 2000;279:L967-76. [11053034]
7. Zakrzewska A, Kobos J, Gryczyńska D. Evaluation of CD25, CD152, Fas-ligand expression in the adenoids of allergic and non-allergic children: a pilot study. Int J Pediatr Otorhinolaryngol 2003; 67:S205-8. [14662196] [doi:10.1016/j.ijporl.2003.08.027]
8. Kern P, Dietrich M, Hemmer C, Wellinghausen N. Increased Levels of Soluble Fas Ligand in Serum in Plasmodium falciparum Malaria. Infect Immun 2000;68:3061-3. [107 69016] [doi:10.1128/ IAI.68.5.3061-3063.2000]
9. Matsumoto J, Kawai S, Terao K, Kirinoki M, Yasutomi Y, Aikawa M, Matsuda H. Malaria infection induces rapid elevation of the soluble Fas ligand level in serum and subsequent T lymphocytopenia: possible factors responsible for the differences in susceptibility of two species of Macaca monkeys to Plasmodium coatneyi infection. Infect Immun 2000;68:1183-8. [10678924] [doi:10.1128/IAI.68.3.1183-1188.2000]
10. Myśliwiec J, Okota M, Nikołajuk A, Górska M. Soluble Fas, Fas ligand and Bcl-2 in autoimmune thyroid diseases: relation to humoral immune response markers. Adv Med Sci 2006; 51:119-22. [17357290]
11. Matute-Bello G, Liles WC, Steinberg KP, Kiener PA, Mongovin S, Chi EY, Jonas M, Martin TR. Soluble fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J Immunol 1999; 163: 2217-25. [10438964]
12. Mezei G, Lévay M, Sepler Z, Héninger E, Kozma GT, Cserháti E. Seasonal changes of proapoptotic soluble Fas ligand level in allergic rhinitis combined with asthma. Pediatr Allergy Immunol 2006:17]:444-9. [16925690] [doi:10.1111 /j.1399-3038.2006.00415.x]
13. O'Byrne P, Bateman ED, Bousquet J, et al. Global Initiative for Asthma (GINA). A Pocket Guide for Physicians and Nurses. Based on the Global Strategy for Asthma management and preventation. GINA Pocket Guide, 2006.
14. Ahn JH, Park SM, Cho HS, Lee MS, Yoon JB, Vilcek J, Lee TH. Non-apoptotic signaling pathways activated by soluble Fas ligand in serum-starved human fibroblasts. Mitogen-activated protein kinases and NF-kappaB-dependent gene expression. J biol chem 2001;276: 47100-6. [11600497] [doi:10.1074/jbc.M107385200]
15. Suda T, Hashimoto H, Tanaka M, Ochi T, Nagata S. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J Exp Med 1997;186:2045-50. [9396774] [doi: 10.1084/jem.186.12.2045]
16. Hokl J, Cerny J, Ondrasek J, Bedanova H, Vespalec J, Sirotkova A. Soluble Fas and Fas-ligand plasma levels in heart transplant recipients treated with neural or tacrolimus. Scripya Medica 2006; 79:163-8.
17. Ikinciogullari A, Dogu F, Bozdogan G, Egin Y, Reisli I, Gokdemir D, Babacan E. Serum sFas and sFas-Ligand Levels in Childhood Asthma. Pediatr Allergy Immunol 2004;17:126-130. [doi:10.1089/ 0883187041269887]
18. Shi ZO, Fischer MJ, De Sanctis GT, Schuyler MR, Tesfaigzi Y. IFN-gamma, but not Fas, mediates reduction of allergen-induced mucous cell metaplasia by inducing apoptosis. J Immunol 2002; 168:4764-71. [11971027]